{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:38Z","timestamp":1790646998091,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1136\/annrheumdis-2012-201750","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T20:47:27Z","timestamp":1347137247000},"page":"1003-1010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":198,"title":["Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis"],"prefix":"10.1016","volume":"72","author":[{"given":"Alfred","family":"Mahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Katsahian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Varet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Christiaan","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R W","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201750_bib1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.2011.150714","article-title":"Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis","volume":"70","author":"Falk","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201750_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201750_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0002-9343(70)80029-8","article-title":"The concept of limited forms of Wegener's granulomatosis","volume":"49","author":"Cassan","year":"1970","journal-title":"Am J Med"},{"key":"10.1136\/annrheumdis-2012-201750_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9343(66)90214-2","article-title":"Limited forms of angiitis and granulomatosis of Wegener's type","volume":"41","author":"Carrington","year":"1966","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1136\/annrheumdis-2012-201750_bib5","first-page":"29","article-title":"European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials","volume":"101","author":"European Community Study Group on Clinical Trials in Systemic Vasculitis ECSYSVASTRIAL","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/annrheumdis-2012-201750_bib6","series-title":"Cluster analysis. A concise guide to market research","first-page":"237","author":"Mooi","year":"2011"},{"key":"10.1136\/annrheumdis-2012-201750_bib7","series-title":"SPSS 15.0 Statistical Procedures Companion. Cluster analysis","first-page":"361","author":"Norusis","year":"2007"},{"key":"10.1136\/annrheumdis-2012-201750_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/096228029200100103","article-title":"Cluster analysis and related techniques in medical research","volume":"1","author":"McLachlan","year":"1992","journal-title":"Stat Methods Med Res"},{"key":"10.1136\/annrheumdis-2012-201750_bib9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201750_bib10","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"de Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201750_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201750_bib12","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201750_bib13","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201750_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1136\/annrheumdis-2012-201750_bib15","first-page":"13","article-title":"European collaborative trials in vasculitis: EUVAS-update and latest results","volume":"120","author":"Jayne","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/annrheumdis-2012-201750_bib16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard.2010.145250","article-title":"Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials","volume":"70","author":"Heijl","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201750_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201750_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201750_bib19","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"10.1136\/annrheumdis-2012-201750_bib20","series-title":"Analyse de donn\u00e9es avec R","author":"Husson","year":"2009"},{"key":"10.1136\/annrheumdis-2012-201750_bib21","series-title":"An R and S-Plus\u00ae Companion to multivariate analysis","author":"Everitt","year":"2005"},{"key":"10.1136\/annrheumdis-2012-201750_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J Stat Softw"},{"key":"10.1136\/annrheumdis-2012-201750_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1136\/annrheumdis-2012-201750_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life table tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1136\/annrheumdis-2012-201750_bib25","unstructured":"Therneau TM, Atkinson B, Ripley B,. rpart: Recursive Partitioning. R package version 3.1-50. http:\/\/CRAN.R-project.org\/package=rpart."},{"key":"10.1136\/annrheumdis-2012-201750_bib26","series-title":"Cluster-wise assessment of cluster stability","author":"Henning","year":"2006"},{"key":"10.1136\/annrheumdis-2012-201750_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/rheumatology\/40.5.492","article-title":"Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up","volume":"40","author":"Mahr","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201750_bib28","first-page":"161","article-title":"Classical versus non-renal Wegener's granulomatosis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"10.1136\/annrheumdis-2012-201750_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement","volume":"9","author":"Westman","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2012-201750_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20082","article-title":"Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients","volume":"51","author":"Bligny","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201750_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.berh.2009.02.002","article-title":"Cardiovascular involvement in primary systemic vasculitis","volume":"23","author":"Mukhtyar","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201750_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2012-201750_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2012-201750_bib34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/rheumatology\/41.5.572","article-title":"Predictors of survival and organ damage in Wegener's granulomatosis","volume":"41","author":"Koldingsnes","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201750_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2012-201750_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hci015","article-title":"Primary systemic vasculitis: clinical features and mortality","volume":"98","author":"Lane","year":"2005","journal-title":"QJM"},{"key":"10.1136\/annrheumdis-2012-201750_bib37","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201750_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4757-9182-2_29","article-title":"Vasculitis from the rheumatologist's viewpoint","volume":"336","author":"Bacon","year":"1993","journal-title":"Adv Exp Med Biol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724214928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724214928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T10:28:28Z","timestamp":1736072908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724214928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0003496724214928"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201750","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 2013 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}